141 related articles for article (PubMed ID: 11232979)
21. Time trends of overall survival and survival after recurrence in completely resected stage I non-small cell lung cancer.
Hung JJ; Jeng WJ; Hsu WH; Huang BS; Wu YC
J Thorac Oncol; 2012 Feb; 7(2):397-405. PubMed ID: 22173701
[TBL] [Abstract][Full Text] [Related]
22. The significance of intrapulmonary metastasis in non-small cell lung cancer: upstaging or downstaging? A re-appraisal for the next TNM staging system.
Oliaro A; Filosso PL; Cavallo A; Giobbe R; Mossetti C; Lyberis P; Cristofori RC; Ruffini E
Eur J Cardiothorac Surg; 2008 Aug; 34(2):438-43; discussion 443. PubMed ID: 18502660
[TBL] [Abstract][Full Text] [Related]
23. Prognosis of ipsilateral intrapulmonary metastases in resected nonsmall cell lung cancer.
Fukuse T; Hirata T; Tanaka F; Yanagihara K; Hitomi S; Wada H
Eur J Cardiothorac Surg; 1997 Aug; 12(2):218-23. PubMed ID: 9288510
[TBL] [Abstract][Full Text] [Related]
24. Significance of the presence of microscopic vascular invasion after complete resection of Stage I-II pT1-T2N0 non-small cell lung cancer and its relation with T-Size categories: did the 2009 7th edition of the TNM staging system miss something?
Ruffini E; Asioli S; Filosso PL; Buffoni L; Bruna MC; Mossetti C; Solidoro P; Oliaro A
J Thorac Oncol; 2011 Feb; 6(2):319-26. PubMed ID: 21164365
[TBL] [Abstract][Full Text] [Related]
25. Lymphovascular invasion in non-small-cell lung cancer: implications for staging and adjuvant therapy.
Higgins KA; Chino JP; Ready N; D'Amico TA; Berry MF; Sporn T; Boyd J; Kelsey CR
J Thorac Oncol; 2012 Jul; 7(7):1141-7. PubMed ID: 22617241
[TBL] [Abstract][Full Text] [Related]
26. Predictors of death, local recurrence, and distant metastasis in completely resected pathological stage-I non-small-cell lung cancer.
Hung JJ; Jeng WJ; Hsu WH; Chou TY; Huang BS; Wu YC
J Thorac Oncol; 2012 Jul; 7(7):1115-23. PubMed ID: 22592210
[TBL] [Abstract][Full Text] [Related]
27. [The stratification of surgically treated T4 (stage IIIb) primary lung cancers; analysis of cases with intrapulmonary metastases in the same lobe as the primary tumors (pm 1) and invading adjacent organs].
Harada H; Nishio W; Sakamoto T; Uchino K; Matsuoka H; Tsubota N
Kyobu Geka; 2003 Jul; 56(7):541-4. PubMed ID: 12854459
[TBL] [Abstract][Full Text] [Related]
28. Poor prognosis after lung resection for patients with adenosquamous carcinoma of the lung.
Nakagawa K; Yasumitu T; Fukuhara K; Shiono H; Kikui M
Ann Thorac Surg; 2003 Jun; 75(6):1740-4. PubMed ID: 12822609
[TBL] [Abstract][Full Text] [Related]
29. Impact of the new lung cancer staging system for a predominantly advanced-disease patient population.
Chien CR; Yang ST; Chen CY; Fang HY; Tu CY; Tseng GC; Yu YH; Chen HJ; Ho CT; Hsieh CY; Chen HN; Chen PR; Liu JC; Wang YC; Wu HH; Hsia TC
J Thorac Oncol; 2010 Mar; 5(3):340-3. PubMed ID: 20186024
[TBL] [Abstract][Full Text] [Related]
30. Adenosquamous carcinoma of the lung: surgical results as compared with squamous cell and adenocarcinoma cases.
Maeda H; Matsumura A; Kawabata T; Suito T; Kawashima O; Watanabe T; Okabayashi K; Kubota I;
Eur J Cardiothorac Surg; 2012 Feb; 41(2):357-61. PubMed ID: 21737295
[TBL] [Abstract][Full Text] [Related]
31. Prognostic impact of number of resected and involved lymph nodes at complete resection on survival in non-small cell lung cancer.
Saji H; Tsuboi M; Yoshida K; Kato Y; Nomura M; Matsubayashi J; Nagao T; Kakihana M; Usuda J; Kajiwara N; Ohira T; Ikeda N
J Thorac Oncol; 2011 Nov; 6(11):1865-71. PubMed ID: 21964529
[TBL] [Abstract][Full Text] [Related]
32. Prognosis and survival in resected lung carcinoma based on the new international staging system.
Naruke T; Goya T; Tsuchiya R; Suemasu K
J Thorac Cardiovasc Surg; 1988 Sep; 96(3):440-7. PubMed ID: 2842549
[TBL] [Abstract][Full Text] [Related]
33. Characteristics and prognosis of patients after resection of nonsmall cell lung carcinoma measuring 2 cm or less in greatest dimension.
Okada M; Sakamoto T; Nishio W; Uchino K; Tsubota N
Cancer; 2003 Aug; 98(3):535-41. PubMed ID: 12879471
[TBL] [Abstract][Full Text] [Related]
34. Effects of reclassification from the TNM-6 into the TNM-7 staging system in bronchoplastic resection for non-small cell lung cancer.
Klikovits T; End A; Riedl G; Stiebler M; Dekan G; Klepetko W
Interact Cardiovasc Thorac Surg; 2011 Jul; 13(1):29-34. PubMed ID: 21525027
[TBL] [Abstract][Full Text] [Related]
35. Identification of subsets of patients with favorable prognosis after recurrence in completely resected non-small cell lung cancer.
Sonobe M; Yamada T; Sato M; Menju T; Aoyama A; Sato T; Chen F; Omasa M; Bando T; Date H
Ann Surg Oncol; 2014 Aug; 21(8):2546-54. PubMed ID: 24633668
[TBL] [Abstract][Full Text] [Related]
36. Survival and treatment of non-small cell lung cancer stage I-II treated surgically or with stereotactic body radiotherapy: patient and tumor-specific factors affect the prognosis.
Mokhles S; Nuyttens JJ; Maat AP; Birim Ö; Aerts JG; Bogers AJ; Takkenberg JJ
Ann Surg Oncol; 2015 Jan; 22(1):316-23. PubMed ID: 24962941
[TBL] [Abstract][Full Text] [Related]
37. Completing the audit cycle improves surgical standards in lung cancer. Why do some patients still not receive the best care?
Hagan ME; Williams ST; Socci L; Malik M; Internullo E; Martin-Ucar AE
J Thorac Oncol; 2013 Jun; 8(6):779-82. PubMed ID: 23612464
[TBL] [Abstract][Full Text] [Related]
38. Which is the better prognostic factor for resected non-small cell lung cancer: the number of metastatic lymph nodes or the currently used nodal stage classification?
Wei S; Asamura H; Kawachi R; Sakurai H; Watanabe S
J Thorac Oncol; 2011 Feb; 6(2):310-8. PubMed ID: 21206387
[TBL] [Abstract][Full Text] [Related]
39. The impact of superior mediastinal lymph node metastases on prognosis in non-small cell lung cancer located in the right middle lobe.
Sakao Y; Okumura S; Mingyon M; Uehara H; Ishikawa Y; Nakagawa K
J Thorac Oncol; 2011 Mar; 6(3):494-9. PubMed ID: 21266920
[TBL] [Abstract][Full Text] [Related]
40. The prognostic value of ratio-based lymph node staging in resected non-small-cell lung cancer.
Qiu C; Dong W; Su B; Liu Q; Du J
J Thorac Oncol; 2013 Apr; 8(4):429-35. PubMed ID: 23486264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
